You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017

The prize is awarded to the companies that made the best use of the capital markets

read more 

CORPORATE

Kedrion Biopharma joins Columbia University to celebrate 50 years of Anti-D

Since 1968, billions of babies have been saved from Hemolytic Disease of the Fetus and Newborn

read more 

CORPORATE

Hemophilia: Kedrion signs on to groundbreaking PARTNERS programme

Goal is to improve access to replacement therapies for coagulation disorders in Europe

read more 
  1. PLASMA & BIOTHERAPIES - 27-11-2013

    Distribution of the first recombinant Factor VIII from human cells

    Kedrion to be the distributor in Italy over the next ten years. The indication is the treatment of…

    read more 
  2. CORPORATE - 11-11-2013

    Kedrion and La Kelley Communication for a donation in Pakistan

    500,000 IU of Factor IX shipped to the Pakistan Hemophilia Patients Welfare Society Rawalpindi.

    read more 
  3. CORPORATE - 07-10-2013

    Kedrion donates 1 million IU of FIX to support WHF Humanitarian Aid Program

    The aim is to broaden access to haemophilia treatment regardless of the patients’ geographical location.

    read more 

Pages

For more information please contact: pressoffice@kedrion.com